TY - JOUR T1 - TIME-Seq Enables Scalable and Inexpensive Epigenetic Age Predictions JF - bioRxiv DO - 10.1101/2021.10.25.465725 SP - 2021.10.25.465725 AU - Patrick T Griffin AU - Alice E Kane AU - Alexandre Trapp AU - Jien Li AU - Matthew Arnold AU - Jesse R Poganik AU - Maeve S McNamara AU - Margarita V Meer AU - Noah Hoffman AU - João Amorim AU - Xiao Tian AU - Michael R MacArthur AU - Sarah J Mitchell AU - Amber L Mueller AU - Colleen Carmody AU - Daniel L Vera AU - Csaba Kerepesi AU - Nicole Noren Hooten AU - James R Mitchell AU - Michele K Evans AU - Vadim N Gladyshev AU - David A Sinclair Y1 - 2022/01/01 UR - http://biorxiv.org/content/early/2022/11/10/2021.10.25.465725.abstract N2 - Epigenetic “clocks” based on DNA methylation (DNAme) have emerged as the most robust and widely employed aging biomarkers, but conventional methods for applying them are expensive and laborious. Here, we develop Tagmentation-based Indexing for Methylation Sequencing (TIME-Seq), a highly multiplexed and scalable method for low-cost epigenetic clocks. Using TIME-Seq, we applied multi-tissue and tissue-specific epigenetic clocks to over 1,600 mouse DNA samples. We also discovered a novel approach for age prediction from shallow sequencing (e.g., 10,000 reads) by adapting scAge for bulk measurements. In benchmarking experiments, TIME-Seq performed favorably against prevailing methods and could quantify the effects of interventions thought to accelerate, slow, and reverse aging in mice. Finally, we built and validated a highly accurate human blood clock from 1,056 demographically representative individuals. Our methods increase the scalability and reduce the cost of epigenetic age predictions by more than 100-fold, enabling accurate aging biomarkers to be applied in more large-scale animal and human studies.Competing Interest StatementP.T.G. and D.A.S. are named inventors on a patent application related to TIME-Seq methods filed by Harvard Medical School and licensed to Tally Health. D.A.S is a founder, investor, and equity owner for Tally Health and P.T.G. has received minor equity compensation as a consultant to Tally Health. Additional info on D.A.S. affiliations not directly related to this work can be found at sinclair.hms.harvard.edu/david-sinclairs-affiliations. A.T., C.K., and V.N.G. are named inventors on a patent application related to scAge filed by Brigham and Women's Hospital. All other authors have nothing to disclose. ER -